PulseGLP
PulseGLP Wiki

Before-and-After Weight Loss Ad Risk Guide

A PulseGLP reference for transformation creative, before-and-after framing, and claim-risk patterns in weight loss ads.

Last updated: 2026-05-26. This page is generated from the PulseGLP second brain and should be treated as market-intelligence context, not medical or legal advice.

Current Signal Snapshot

  • 7,503 matching patient-evidence rows in the last 180 days.
  • 1,946 matching Meta ad observations in the last 180 days.
  • 402 matching FDA warning-letter findings in the enforcement corpus.
  • Newest matching patient evidence was observed 5/22/2026.
  • Newest matching ad observation was seen 5/22/2026.

Patient Evidence Patterns

  • Top drug/entity mix in sampled evidence: Retatrutide (12), GLP-1 (6), Tirzepatide (6), Zepbound (5), Semaglutide (4), Mounjaro (3).
  • Highest-volume sampled sources: r/Retatrutide (12), r/GLP1 (6), r/Tirzepatide (6), r/Zepbound (5), r/Semaglutide (4), r/Mounjaro (3).
  • Classification mix in sampled evidence: Positive (16), Risk-Alert (11), Neutral-Low (5), Analytical (4).
  • Use Ask Pulse to inspect source-level citations before turning this signal into campaign copy, clinical workflow changes, or compliance guidance.

FDA And Compliance Context

  • Most common matching warning-letter finding types: sameness-or-fda-approval-implication (12), product-sourcing-ambiguity (6).
  • Recent companies/products represented in matching findings include Belle Health LLC dba Belle / Drugs; Dripgym Mobile Parent, LLC dba Amp Health / Drugs; Alan Health Technologies Inc. dba Alan / Drugs; 24HrDoc, Inc. dba 24HrDoc / Drugs; NewSelf Limited dba NewSelf / Drugs.
  • PulseGLP tracks potential FDA-cited language patterns; it does not determine whether a claim is compliant or non-compliant.

Ad Market Signals

  • Advertisers appearing in the sampled matching set: Nutral (2), River City Wellness & Weight Loss -formerly The Wellborn Clinic (2), Best Life Primary Care (1), Decalo Weight Loss (1), Get Zappy Health (1), Hydreight (1).
  • Creative Intelligence can inspect the underlying ads for risk-level labels, themes, landing URLs, and repeated positioning patterns.
  • Ad counts reflect observed library rows and can include deduped or updated observations from recovered collection runs.

How Ask Pulse Uses This Page

  • Ask Pulse retrieves this page as durable context before it looks at fresh raw evidence.
  • The page helps keep answers consistent across repeated questions about the same topic.
  • Raw evidence citations are still required for specific factual claims or patient-language details.

Related PulseGLP Wiki Pages

9,851 matched sources Confidence 95/100 Updated 5/26/2026